Posted by
Influential U.S. Panel Backs PrEP HIV-Prevention Pills

Influential U.S. Panel Backs PrEP HIV-Prevention Pills

Latest HIV News TUESDAY, Nov. 20, 2018 (HealthDay News) — For the first time, a highly influential panel of experts says doctors should offer a daily pill to prevent HIV transmission to people who are at high risk for infection with the AIDS-causing virus. This treatment is called pre-exposure prophylaxis — PrEP for short — […]

Posted by
Enfuvirtide (Fuzeon)

Enfuvirtide (Fuzeon)

What is enfuvirtide (Fuzeon), and what is it used for? Fuzeon in combination with other antiretroviral agents is indicated for the treatment of HIV-1 infection in treatment-experienced patients with evidence of HIV-1 replication despite ongoing antiretroviral therapy. This indication is based on results from two controlled studies of 48 weeks duration. Subjects enrolled were treatment-experienced […]

Posted by
Etravirine (Intelence)

Etravirine (Intelence)

What is etravirine (Intelence), and what is it used for? Intelence, in combination with other antiretroviral agents, is indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in antiretroviral treatment-experienced patients ages 2 years and older, who have evidence of viral replication and HIV-1 strains resistant to a non-nucleoside reverse transcriptase inhibitor […]

Posted by
Acquired Immunodeficiency Syndrome

Acquired Immunodeficiency Syndrome

What is the treatment for non-HIV-infected people exposed to the genital secretions or blood of someone with HIV? Blood and genital secretions from people with HIV are infectious and the utmost care should be taken in handling them. Fluids contaminated with blood also are potentially infectious. Feces, nasal secretions, saliva, sputum, sweat, tears, urine, and […]

Posted by
Tipranavir (Aptivus)

Tipranavir (Aptivus)

What is tipranavir (Aptivus), and what is it used for? Aptivus (tipranavir), co-administered with 200 mg of ritonavir, is indicated for combination antiretroviral treatment of HIV-1 infected adult patients with evidence of viral replication, who are highly treatment-experienced or have HIV-1 strains resistant to multiple protease inhibitors. This indication is based on analyses of plasma […]

Posted by
New Therapy May Control HIV Without Daily Pills

New Therapy May Control HIV Without Daily Pills

By Amy NortonHealthDay Reporter Latest HIV News WEDNESDAY, Sept. 26, 2018 (HealthDay News) — A combination of two HIV-fighting antibodies can suppress the virus in some patients, even after they stop standard drugs, a preliminary trial has shown. Researchers found that among 11 HIV patients given the antibody combo, nine maintained complete suppression of the […]